Is Opko Health Stock a Good Investment?
Opko Health Investment Advice | OPK |
- Examine Opko Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Opko Health's leadership team and their track record. Good management can help Opko Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Opko Health's business and its evolving consumer preferences.
- Compare Opko Health's performance and market position to its competitors. Analyze how Opko Health is positioned in terms of product offerings, innovation, and market share.
- Check if Opko Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Opko Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Opko Health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Opko Health is a good investment.
Sell | Buy |
Sell
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Opko Health Stock
Researching Opko Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 54.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.76. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Opko Health recorded a loss per share of 0.19. The entity had not issued any dividends in recent years.
To determine if Opko Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Opko Health's research are outlined below:
| Opko Health generated a negative expected return over the last 90 days | |
| Opko Health may become a speculative penny stock | |
| The company reported the last year's revenue of 863.5 M. Reported Net Loss for the year was (188.86 M) with profit before taxes, overhead, and interest of 214.3 M. | |
| Opko Health has about 210.46 M in cash with (28.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. | |
| Opko Health has a poor financial position based on the latest SEC disclosures | |
| Roughly 54.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Phillip Frost of 100000 shares of Opko Health at 1.59 subject to Rule 16b-3 |
Opko Health Quarterly Cash And Short Term Investments |
|
Opko Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Opko Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Opko Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Opko Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Opko Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2016-02-29 | 2015-12-31 | 0.0017 | 0.0029 | 0.0012 | 70 | ||
2023-11-06 | 2023-09-30 | -0.1 | -0.11 | -0.01 | 10 | ||
2021-02-18 | 2020-12-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2017-08-08 | 2017-06-30 | -0.05 | -0.04 | 0.01 | 20 | ||
2014-05-09 | 2014-03-31 | -0.1 | -0.11 | -0.01 | 10 | ||
2013-08-09 | 2013-06-30 | -0.05 | -0.04 | 0.01 | 20 | ||
2013-05-09 | 2013-03-31 | -0.04 | -0.03 | 0.01 | 25 | ||
2012-08-09 | 2012-06-30 | -0.03 | -0.04 | -0.01 | 33 |
Know Opko Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Opko Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Opko Health backward and forwards among themselves. Opko Health's institutional investor refers to the entity that pools money to purchase Opko Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 2.3 M | Portolan Capital Management, Llc | 2024-06-30 | 1.9 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.6 M | Assenagon Asset Management Sa | 2024-09-30 | 1.5 M | Y.d. More Investments Ltd | 2024-06-30 | 1.5 M | Bank Of New York Mellon Corp | 2024-06-30 | 1.4 M | Norges Bank | 2024-06-30 | 1.3 M | Awm Investment Company Inc | 2024-09-30 | 1.3 M | Jpmorgan Chase & Co | 2024-06-30 | 1.3 M | Rubric Capital Management Lp | 2024-06-30 | 44.4 M | Blackrock Inc | 2024-06-30 | 29.2 M |
Opko Health's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.06 B.Market Cap |
|
Opko Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.39) | (0.41) | |
| Return On Capital Employed | (0.09) | (0.09) | |
| Return On Assets | (0.09) | (0.10) | |
| Return On Equity | (0.14) | (0.14) |
Determining Opko Health's profitability involves analyzing its financial statements and using various financial metrics to determine if Opko Health is a good buy. For example, gross profit margin measures Opko Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Opko Health's profitability and make more informed investment decisions.
Evaluate Opko Health's management efficiency
Opko Health has Return on Asset of (0.0897) % which means that on every $100 spent on assets, it lost $0.0897. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0939) %, meaning that it generated no profit with money invested by stockholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.41. The value of Return On Capital Employed is expected to slide to -0.09. At this time, Opko Health's Liabilities And Stockholders Equity is quite stable compared to the past year. Change To Liabilities is expected to grow at the current pace this year, although the value of Total Current Liabilities will most likely fall to about 103.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.85 | 1.18 | |
| Tangible Book Value Per Share | (0.19) | (0.18) | |
| Enterprise Value Over EBITDA | (20.85) | (19.81) | |
| Price Book Value Ratio | 0.82 | 0.78 | |
| Enterprise Value Multiple | (20.85) | (19.81) | |
| Price Fair Value | 0.82 | 0.78 | |
| Enterprise Value | 1.4 B | 1.5 B |
Effective leadership at Opko Health drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Beta 1.647 |
Basic technical analysis of Opko Stock
As of the 24th of November, Opko Health holds the Coefficient Of Variation of 361541.7, semi deviation of 2.17, and Risk Adjusted Performance of 0.0071. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Opko Health, as well as the relationship between them.Opko Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opko Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opko Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Opko Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Opko Health's Outstanding Corporate Bonds
Opko Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Opko Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Opko bonds can be classified according to their maturity, which is the date when Opko Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US683715AD87 Corp BondUS683715AD87 | View | |
| OTEXCN 69 01 DEC 27 Corp BondUS683715AF36 | View | |
| Open Text Corp BondUS683715AC05 | View | |
| US683720AC08 Corp BondUS683720AC08 | View | |
| Open Text Corp BondUS683720AA42 | View |
Understand Opko Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Opko Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0071 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 1.78 | |||
| Semi Deviation | 2.17 | |||
| Downside Deviation | 2.58 | |||
| Coefficient Of Variation | 361541.7 | |||
| Standard Deviation | 2.44 | |||
| Variance | 5.94 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | (0.05) | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 12.58 | |||
| Value At Risk | (3.64) | |||
| Potential Upside | 4.83 | |||
| Downside Variance | 6.66 | |||
| Semi Variance | 4.73 | |||
| Expected Short fall | (2.18) | |||
| Skewness | 0.2436 | |||
| Kurtosis | 1.17 |
| Risk Adjusted Performance | 0.0071 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 1.78 | |||
| Semi Deviation | 2.17 | |||
| Downside Deviation | 2.58 | |||
| Coefficient Of Variation | 361541.7 | |||
| Standard Deviation | 2.44 | |||
| Variance | 5.94 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | (0.05) | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 12.58 | |||
| Value At Risk | (3.64) | |||
| Potential Upside | 4.83 | |||
| Downside Variance | 6.66 | |||
| Semi Variance | 4.73 | |||
| Expected Short fall | (2.18) | |||
| Skewness | 0.2436 | |||
| Kurtosis | 1.17 |
Consider Opko Health's intraday indicators
Opko Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Opko Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Opko Health time-series forecasting models is one of many Opko Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Opko Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Opko Stock media impact
Far too much social signal, news, headlines, and media speculation about Opko Health that are available to investors today. That information is available publicly through Opko media outlets and privately through word of mouth or via Opko internal channels. However, regardless of the origin, that massive amount of Opko data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Opko Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Opko Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Opko Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Opko Health alpha.
Opko Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Opko Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Opko Health Corporate Executives
Elected by the shareholders, the Opko Health's board of directors comprises two types of representatives: Opko Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opko. The board's role is to monitor Opko Health's management team and ensure that shareholders' interests are well served. Opko Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opko Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Adam Logal | CFO, Chief Accounting Officer, Sr. VP and Treasurer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.19) | Revenue Per Share 0.998 | Quarterly Revenue Growth (0.03) | Return On Assets (0.09) |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Opko Health's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.